INVO Bioscience 

$0.8330
36
-$0.03-2.91% Monday 20:00

Statistics

Day High
0.88
Day Low
0.8171
52W High
3.5
52W Low
0.63
Volume
124,018
Avg. Volume
1,175,932
Mkt Cap
0
P/E Ratio
1.21
Dividend Yield
-
Dividend
-

Earnings

29NovExpected
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q3 2024
-4.2
-2.83
-1.46
-0.09
Expected EPS
-0.09
Actual EPS
N/A

Financials

-265.97%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
6.04MRevenue
-16.07MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Miscellaneous
Manufacturing
Surgical and Medical Instrument Manufacturing
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Show more...
CEO
Employees
25
Country
United States
ISIN
US44984F3029

Listings

0 Comments

Share your thoughts

FAQ

What is INVO Bioscience stock price today?
The current price of INVO is $0.83 USD — it has decreased by -2.91% in the past 24 hours. Watch INVO Bioscience stock price performance more closely on the chart.
What is INVO Bioscience stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange INVO Bioscience stocks are traded under the ticker INVO.
What is INVO Bioscience revenue for the last year?
INVO Bioscience revenue for the last year amounts to 6.04M USD.
What is INVO Bioscience net income for the last year?
INVO net income for the last year is -16.07M USD.
How many employees does INVO Bioscience have?
As of September 04, 2026, the company has 25 employees.
In which sector is INVO Bioscience located?
INVO Bioscience operates in the Manufacturing sector.
When did INVO Bioscience complete a stock split?
The last stock split for INVO Bioscience was on July 28, 2023 with a ratio of 1:20.